
BrainsWay is a medical devices business based in the US. BrainsWay stocks (BWAY.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $9.75 – a decrease of 15.77% over the previous week. BrainsWay employs 118 staff and has a trailing 12-month revenue of around $29.7 million.
How to buy stocks in BrainsWay
- Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BWAY – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Finder's Pick for
Beginners

Finder's Pick for
Free Trades

Finder's Pick for
Commodity Stocks

Finder's Pick for
US Stocks

What's in this guide?
- Can I buy shares in BrainsWay?
- Has coronavirus impacted BrainsWay shares?
- BrainsWay shares summary
- Compare share dealing platforms
- Is BrainsWay stock a buy or sell?
- BrainsWay performance over time
- BrainsWay's financials
- How volatile are BrainsWay shares?
- Does BrainsWay pay a dividend?
- Other common questions
BrainsWay stock price (NASDAQ:BWAY)
Use our graph to track the performance of BWAY stocks over time.BrainsWay shares at a glance
Latest market close | $5.45 |
---|---|
52-week range | $5.03 - $11.77 |
50-day moving average | $7.89 |
200-day moving average | $7.91 |
Wall St. target price | $14.50 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.41 |
Compare stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy BrainsWay stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
BrainsWay price performance over time
Historical closes compared with the close of $5.45 from 2022-05-13
1 week (2022-05-06) | -23.56% |
---|---|
1 month (2022-04-12) | -32.96% |
3 months (2022-02-16) | -30.66% |
6 months (2021-11-16) | -36.26% |
1 year (2021-05-14) | -38.42% |
---|---|
2 years (2020-05-15) | -31.06% |
3 years (2019-05-15) | 10.8 |
5 years (2017-05-12) | N/A |
BrainsWay financials
Revenue TTM | $29.7 million |
---|---|
Gross profit TTM | $24.4 million |
Return on assets TTM | -4.22% |
Return on equity TTM | -16.79% |
Profit margin | -21.79% |
Book value | $3.48 |
Market capitalisation | $90.4 million |
TTM: trailing 12 months
BrainsWay share dividends
We're not expecting BrainsWay to pay a dividend over the next 12 months.
BrainsWay share price volatility
Over the last 12 months, BrainsWay's shares have ranged in value from as little as $5.03 up to $11.767. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BrainsWay's is 0.6849. This would suggest that BrainsWay's shares are less volatile than average (for this exchange).
BrainsWay overview
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. .
BrainsWay in the news
BrainsWay Reports First Quarter 2022 Financial Results and Operational Highlights

Neuronetics files lawsuit against Brainsway for unfair competition

Brainsway reports Q1 EPS (6c) vs (5c) last year
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing

Popular propane stocks to buy in Canada
Here’s what you need to know about investing in the propane industry, including 3 popular propane stocks to watch.
Read more…
Best blue chip stocks in Canada and the US
Using our proprietary algorithm, we’ve found the best blue chip stocks on the TSX, NYSE and Nasdaq based on price, performance and more.
Read more…
Satellite companies stocks
Want to invest in satellite companies? We’ve put together a list of 6 satellite stocks you should keep your eye on.
Read more…More guides on Finder
-
How to buy Hanover Bancorp, Inc. (HNVR) stock in Canada when it goes public
Everything we know about the Hanover Bancorp, Inc. IPO, plus information on how to buy in.
-
How to buy PrimeBlock stock in Canada when it goes public
Everything we know about the PrimeBlock IPO, plus information on how to buy in.
-
How to buy Actelis Networks (ASNS) stock in Canada when it goes public
Everything we know about the Actelis Networks IPO, plus information on how to buy in.
-
How to buy ProFrac Holding Corp (PFHC) stock in Canada when it goes public
Everything we know about the ProFrac Holding Corp IPO, plus information on how to buy in.
-
How to buy Wytec International (WYTC) stock in Canada when it goes public
Everything we know about the Wytec International IPO, plus information on how to buy in.
-
Inflation stocks
Here are some of the best stocks for inflation periods to reduce the negative impacts of inflation on your portfolio.
-
HSBC InvestDirect Review
Choose from many account and investment types to invest in global markets, but expect to pay high commissions with HSBC InvestDirect, which doesn’t have an app.
-
Flahmingo review
Our Flahmingo review tells you how to buy fractional shares of some of your favourite US companies with as little as $1.
-
How to buy Expeditors International of Washington stock in Canada
Steps to owning and managing EXPD stock, with 24-hour and historical pricing before you buy.
-
How to buy Perseus Mining stock in Canada
Steps to owning and managing PRU stock, with 24-hour and historical pricing before you buy.